Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis
Michael Gersemann(Robert Bosch Hospital), Eduard F. Stange(John Radcliffe Hospital), Klaus Fellermann(Apple (Israel)), Joscha Griger(Translational Research in Oncology), Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Irmgard Kübler(Robert Bosch Hospital), Jan Wehkamp(Robert Bosch Hospital), Guoxing Wang(Capital Medical University), Péter Fritz(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Klaus Herrlinger(Robert Bosch Hospital), Maureen J. Koslowski(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology)
Cited by 290
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558